BackPrometheus Biosciences Overview

Prometheus Biosciences Net Income

Profitability analysis for RXDX.

Quarterly Net Income

-$40.88M
27.59% YoY

As of Mar 2023

Annual Net Income (TTM)

-$149.13M
35.6% YoY

Trailing 12 months ending Mar 2023

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...